Skip to main content

Spyre Therapeutics, Inc.

SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636282

In the last 90 days, Spyre Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 265 institutions reported holding it in 13F filings for Q2 2026, worth $8.52B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Spyre Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
129
−1 vs. Q4 2024
Shares held
62.1M
+2.35M (+3.9%) vs. Q4 2024
Total value
$1.00B
−$386.9M (−27.8%) vs. Q4 2024
New holders
20
52 more added
Sold out
21
35 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 129 institutions
Q1 2021: 84 institutionsQ2 2021: 78 institutionsQ3 2021: 77 institutionsQ4 2021: 86 institutionsQ1 2022: 84 institutionsQ2 2022: 67 institutionsQ3 2022: 55 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 44 institutionsQ3 2023: 29 institutionsQ4 2023: 54 institutionsQ1 2024: 103 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 129 institutionsQ2 2025: 129 institutionsQ3 2025: 137 institutionsQ4 2025: 153 institutionsQ1 2026: 198 institutionsQ2 2026: 265 institutions
Value heldQ1 2025: $1.00B
Q1 2021: $328.7MQ2 2021: $285.8MQ3 2021: $322.5MQ4 2021: $189.4MQ1 2022: $95.4MQ2 2022: $24.8MQ3 2022: $23.5MQ4 2022: $19.2MQ1 2023: $12.0MQ2 2023: $31.9MQ3 2023: $43.9MQ4 2023: $601.0MQ1 2024: $1.21BQ2 2024: $1.18BQ3 2024: $1.51BQ4 2024: $1.39BQ1 2025: $1.00BQ2 2025: $952.6MQ3 2025: $1.08BQ4 2025: $2.65BQ1 2026: $4.16BQ2 2026: $8.52B
Institutions holding SYRE and their total value by quarter
QuarterHoldersValue
Q2 2026265$8.52B
Q1 2026198$4.16B
Q4 2025153$2.65B
Q3 2025137$1.08B
Q2 2025129$952.6M
Q1 2025129$1.00B
Q4 2024131$1.39B
Q3 2024119$1.51B
Q2 2024107$1.18B
Q1 2024103$1.21B
Q4 202354$601.0M
Q3 202329$43.9M
Q2 202344$31.9M
Q1 202345$12.0M
Q4 202251$19.2M
Q3 202255$23.5M
Q2 202267$24.8M
Q1 202284$95.4M
Q4 202186$189.4M
Q3 202177$322.5M
Q2 202178$285.8M
Q1 202184$328.7M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Spyre Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding SYRE in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Mirae Asset Global Investments Co., Ltd.2,016$36.2K0.00%+61+3.1%Added
Royal Bank of Canada2,172$35.0K0.00%−1,850−46.0%Reduced
Tower Research Capital LLC (TRC)2,044$33.0K0.00%−6,530−76.2%Reduced
Public Employees Retirement Association of Colorado1,589$26.0K0.00%00.0%Unchanged
GF Fund Management Co. Ltd.1,502$24.2K0.00%+270+21.9%Added
Huntington National Bank1,470$23.7K0.00%00.0%Unchanged
Amalgamated Bank1,379$22.0K0.00%+181+15.1%Added
Sterling Capital Management LLC629$10.1K0.00%−380−37.7%Reduced
CWM, LLC374$6.00K0.00%+366+4,575.0%Added
GAMMA Investing LLC270$4.36K0.00%+270New
Advisor Group Holdings, Inc.238$3.84K0.00%+133+126.7%Added
Daiwa Securities Group Inc.206$3.00K0.00%+206New
Nisa Investment Advisors, LLC184$2.97K0.00%+64+53.3%Added
Aster Capital Management (DIFC) Ltd126$2.48K0.00%+126New
Clear Street Markets LLC133$2.15K0.00%+133New
IFP Advisors, Inc109$1.92K0.00%00.0%Unchanged
Lindbrook Capital, LLC78$1.26K0.00%+78New
Rothschild Investment LLC50$8070.00%+10+25.0%Added
Larson Financial Group LLC44$7100.00%+44New
CoreCap Advisors, LLC41$6620.00%+41New
Caitong International Asset Management Co., Ltd28$4520.00%+14+100.0%Added
EverSource Wealth Advisors, LLC24$3870.00%+16+200.0%Added
Stephens Consulting, LLC20$3230.00%+20New
Parallel Advisors, LLC14$2260.00%+14New
Allworth Financial LP13$1950.00%+4+44.4%Added
US Bancorp9$1450.00%+9New
SBI Securities Co., Ltd.5$810.00%00.0%Unchanged
Amundi5$700.00%−27−84.4%Reduced
Covestor Ltd4$00.00%00.0%Unchanged
Logos Global Management LP0$00.00%−500,000−100.0%Sold out
Boxer Capital Management, LLC0$00.00%−466,680−100.0%Sold out
Ikarian Capital, LLC0$00.00%−282,159−100.0%Sold out
Millennium Management LLC0$00.00%−167,804−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−85,618−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−82,475−100.0%Sold out
First Trust Advisors LP0$00.00%−23,550−100.0%Sold out
Cinctive Capital Management LP0$00.00%−19,567−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−16,899−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−10,383−100.0%Sold out
Two Sigma Investments, LP0$00.00%−9,638−100.0%Sold out
Carlyle Group Inc.0$00.00%−9,620−100.0%Sold out
State Board of Administration of Florida Retirement System0$00.00%−9,030−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−2,972−100.0%Sold out
R Squared Ltd0$00.00%−710−100.0%Sold out
Venturi Wealth Management, LLC0$00.00%−231−100.0%Sold out
Sugar Maple Asset Management, LLC0$00.00%−180−100.0%Sold out
Skopos Labs, Inc.0$00.00%−120−100.0%Sold out
Signaturefd, LLC0$00.00%−68−100.0%Sold out
Simplex Trading, LLC0$00.00%−55−100.0%Sold out
Pacific Capital Wealth Advisors, Inc0$00.00%−8−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed